ADVANCED CLEAR CELL RENAL CELL CARCINOMA
Clinical trials for ADVANCED CLEAR CELL RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED CLEAR CELL RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED CLEAR CELL RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gut bacteria boost may help kidney cancer drugs work better
Disease control OngoingThis early-phase study looks at whether adding a probiotic called CBM588 to the usual two-drug treatment (cabozantinib and nivolumab) can improve outcomes for people with advanced kidney cancer that has spread. The probiotic is meant to increase helpful gut bacteria, which may he…
Matched conditions: ADVANCED CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 05:12 UTC
-
New radiation therapy shows promise for Tough-to-Treat kidney cancer
Disease control OngoingThis study tests a drug called 177Lu-PSMA-617, which delivers radiation directly to cancer cells, in 24 people with advanced clear cell kidney cancer that has spread. The goal is to see if it shrinks tumors and how safe it is. Participants must have a specific marker (PSMA) on th…
Matched conditions: ADVANCED CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 26, 2026 05:11 UTC
-
New hope for kidney cancer: two drug regimens battle after immunotherapy fails
Disease control OngoingThis study tests two different drug treatments for people with advanced kidney cancer that has spread and continued to grow despite prior immunotherapy. About 90 participants will receive either a combination of two drugs (lenvatinib plus everolimus) or a single drug (cabozantini…
Matched conditions: ADVANCED CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 05:06 UTC
-
New hope for advanced kidney cancer: combo therapy enters phase 3 trial
Disease control OngoingThis study tests two new treatments (volrustomig alone or with casdatifan) against the current standard therapy for people with advanced clear cell kidney cancer that has not been treated before. About 1,116 participants worldwide will take part. The goal is to see if the new com…
Matched conditions: ADVANCED CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 22, 2026 13:53 UTC